1-May-2026
No headlines found.
Myomo to Report First Quarter 2026 Financial Results on May 7
Business Wire (Fri, 1-May 4:05 PM ET)
Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement
Business Wire (Mon, 20-Apr 4:05 PM ET)
Myomo Appoints William J Febbo to its Board of Directors
Business Wire (Thu, 16-Apr 4:05 PM ET)
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Business Wire (Mon, 9-Mar 4:06 PM ET)
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation
Business Wire (Mon, 9-Mar 4:05 PM ET)
Myomo to Report Fourth Quarter 2025 Financial Results on March 9
Business Wire (Mon, 2-Mar 4:05 PM ET)
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Myomo trades on the AMEX stock market under the symbol MYO.
As of May 1, 2026, MYO stock price climbed to $0.90 with 323,769 million shares trading.
MYO has a beta of 1.67, meaning it tends to be more sensitive to market movements. MYO has a correlation of 0.06 to the broad based SPY ETF.
MYO has a market cap of $34.77 million. This is considered a Sub-Micro Cap stock.
Last quarter Myomo reported $11 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $1 million and met earnings estimates .
In the last 3 years, MYO traded as high as $7.17 and as low as $.37.
The top ETF exchange traded funds that MYO belongs to (by Net Assets): VTI, IWM, IWO, VXF, VTWO.
MYO has underperformed the market in the last year with a return of -81.0%, while SPY returned +30.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MYO shares. However, MYO has outperformed the market in the last 3 month and 2 week periods, returning +7.2% and +4.7%, while SPY returned +4.4% and +1.5%, respectively. This indicates MYO has been having a stronger performance recently.
MYO support price is $.82 and resistance is $.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MYO shares will trade within this expected range on the day.
